News

Latest Issue of the GIST and Sarcoma Journal is Now Available Online

The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals [...]

By |2018-10-30T09:19:21-04:00May 18th, 2017|News, Research|

National LeioMyoSarcoma Foundation and the Life Raft Group Announce Collaboration

The Life Raft Group is pleased to announce a new collaboration to provide access to our valuable resource tool, SideEQ, to the LeioMyoSarcoma Patient-Family-Care Partner Community. Commencing on May 5, members of [...]

By |2018-10-30T09:19:24-04:00May 9th, 2017|News, Patient Support, Side Effects|

New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients

A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, [...]

By |2018-10-30T09:19:32-04:00February 27th, 2017|News, Research|

Collaboration Lays the Groundwork for Breakthroughs in GIST

This article originally appeared in the January 30th edition of Cure Today. Less than two decades ago, Gleevec (imatinib) drastically changed the frontline treatment for patients with gastrointestinal stromal tumors (GIST). However, as patients [...]

By |2018-10-30T09:20:36-04:00February 24th, 2017|News, Newsletter, Research|

New Study Outlines Novel Approach to Starving Tumors in Sarcomas

A recent study from Washington University School of Medicine in St. Louis outlines a novel approach to starving tumor cells that is based on a vulnerable point in cancer cell metabolism. The study was [...]

By |2018-10-30T09:23:11-04:00February 13th, 2017|News, Research|
Go to Top